Soft Tissue Repair Market - By Product (Tissue Patch/Matrix, Tissue Fixation Devices), By Application (Hernia Repair, Orthopedic, Skin Repair, Dural Repair), By End-use (Hospitals, Clinics) & Forecast, 2022-2030

Industry Overview

Soft Tissue Repair Market size surpassed was valued at over USD 10.2 billion in 2021 and is estimated to register more than 7.8% CAGR between 2022 and 2030 owing to several factors including the surging prevalence of chronic conditions such as hernia, orthopedic diseases, and breast cancer among others.
 

To get more details on this report: Request Free Sample PDF
 

For instance, as per the National Center for Biotechnology Information article published in 2019, the lifetime prevalence of inguinal hernias is estimated to be 27-43% in males and 3-6% in females. Additionally, around 20 million inguinal hernia repairs are performed every year across the globe.
 

The growing geriatric population that is increasingly susceptible to soft tissue injuries is also expected to drive the demand for treatment incorporating soft tissue repair products that would further proliferate the market revenue. Heavy R&D investments by market players such as Smith & Nephew Plc., Medtronic Plc., and Arthrex, Inc. among others leading to the introduction of a wide range of soft tissue repair products are anticipated to drive the soft tissue repair market share globally.
 

Soft tissue repair products are defined as the use of any material to be applied in the repair of muscle, fibrous tissue or fascia, blood vessels, and/or other supporting connective tissues. It involves the replacement of the injured or damaged tissues with healthy tissues. Soft tissue repair product comprises tissue patch/matrix and tissue fixation devices.
 

However, the high cost associated with soft tissue repair procedures is among the major factors hampering product adoption. For instance, a soft tissue repair of the anterior cruciate ligament (ACL) cost around USD 20,000 to USD 50,000 for people without medical coverage including the surgeon fee, facility fee, anesthesia, and graft. In low-middle income countries, such a high cost of procedure prohibits most of the patients from opting for the procedures.
 

Similarly, the high cost of acquisition of these products hampers their adoption rate, especially in the emerging markets. The excessive cost along with the unfavourable reimbursement scenario for these soft tissue repair products in several nations makes them unaffordable for a large section of the target patient population. 
 

The recent outbreak of COVID-19 has negatively impacted the soft tissue repair market revenue. The augmented demand for COVID-19 treatment has significantly impacted other disease treatments comprising soft tissue repair procedures. In 2020, the incidence, as well as the mortality rate due to coronavirus was highest and people preferred to avoid any other treatment procedures at healthcare facilities.
 

For instance, Herniamed reported a 75% decrease in the hernia surgeries performed during March 2020, as compared to the same period in 2019 in Germany. The U.S. declared a national emergency and a ban on all elective surgical procedures in outpatient and inpatient settings. Such variables had impacted the growth of the soft tissue repair market in several countries across the globe.
 

However, in 2021, the technological advancements and incorporation of telemedicine have augmented target disease diagnosis and treatment compliance and promoted the acceptance of tissue repair products. In addition, some of the surgeries if not performed on time may lead to the death of patients. Hence, despite the coronavirus crisis, such emergency surgical procedures are performed in healthcare facilities across the world. These essential surgeries mainly include soft-tissue surgeries of the lower extremity that comprise cartilage resections or repairs, muscle repairs, fasciotomies, tendon transfers, etc.
 

Moreover, as the number of COVID-19-affected patients reduced in several countries globally, the healthcare facilities resumed providing healthcare services including tissue repair procedures and steadily restoring the procedural volume to the pre-pandemic level. Thus, the COVID-19 pandemic has slightly affected the soft tissue repair market in the shorter run; however, the declining COVID-19 infection rates & patients and rising procedural volume are set to facilitate the market growth in the coming years.
 

Increasing prevalence of orthopedic conditions is anticipated to amplify the market statistics

Rising prevalence of orthopedic conditions is some of the key variables driving the global soft tissue repair market. Out of the 33 million musculoskeletal injuries that are reported in the U.S. every year, around 50% involve soft tissue injuries, including tendons and ligaments. Suture anchors are largely applied for connecting soft tissue (e.g., tendons and ligaments) to the bone and have become essential devices during orthopedic surgery because it allows simple and efficient fixation of soft tissue.
 

As a result, suture anchor manufacturers are continually focusing to develop more safe and efficient products. Interference screws are also an extensively used method of fixation during anterior cruciate ligament (ACL) reconstruction for soft tissue–to–bone fixation.  According to an article published in 2021, the annual incidence of rheumatoid arthritis is surging with a rapidly aging population and is highest in people aged 35-50 years.
 

The incorporation of novel soft tissue repair products in such procedures has enabled surgeons to work accurately and efficiently. The introduction of technologically advanced tissue fixation devices has revolutionized orthopedic surgery across the globe. Hence, owing to the above variables rising prevalence of orthopedic disorders is set to increase the demand for tissue repair procedures that will prove beneficial for the soft tissue repair market
demand.

The advent of novel tissue patch/matrix is set to stimulate the business landscape

To get more details on this report: Request Free Sample PDF
 

Based on product, the tissue patch/matrix segment held the majority market share in 2021 and was valued at more than USD 6,779 million owing to soaring demand and rising awareness regarding the benefits offered by tissue patch/matrix in soft tissue repair procedures. As per the U.S. FDA, using hernia matrix may enhance a patient’s outcome because the repair procedure and recovery may take less time compared to other treatment options. Further, some studies have shown that surgeries using tissue matrix led to fewer hernia recurrences.
 

Market players are also emphasizing on the designing of novel soft tissue patches to meet the needs of the most demanding soft tissue repairs with minimal complications. Thus, the preference for innovative tissue patches is significantly surging attributable to a smart design that offers greater suture retention, inert material that minimizes foreign body response, etc.
 

The surging prevalence of orthopedic diseases is set to stimulate the business outlook

Based on application, the orthopedic segment held a substantial market share in 2021 and is expected to reach USD 5,776 million by 2030 due to the rising demand and increasing awareness related to extensive advantages delivered by the tissue repair products in the management of multiple orthopedic conditions. The advent of novel technologies comprising biological meshes, bioprinting, and bio fabrication to treat such disease conditions is anticipated to boost the segment revenue.
 

With the augmented activity of an elderly population, the product demand is also expected to upsurge in the coming years. According to the International Osteoporosis Foundation, the total number of hip fractures is expected to reach 6.26 million by 2050.  As a result, a number of individuals suffering from orthopedic diseases and the availability of high-quality products are projected to boost the industry growth positively in the coming years.
 

Rising advantages delivered by hospitals in soft tissue repair procedures is expected to spur segmental revenue

To get more details on this report: Request Free Sample PDF
 

Based on end-use, the hospitals segment held a dominant market share in 2021 and is estimated to witness substantial growth to reach more than USD 10,439 million by 2030 owing to the soaring use of novel tissue repair products in hospital settings delivering rapid and reliable outcomes is estimated to surge the patient preference for these healthcare facilities. The availability of a broad spectrum of technologically advanced tissue fixation devices for performing these surgical procedures with proven accuracy will drive product preference in hospitals.
 

Growing admissions with chronic soft tissue injuries and the growing popularity of minimally invasive therapies along with the accessibility to board-certified healthcare professionals are some other variables that are augmenting the segmental growth positively. Furthermore, the rising disease burden in developed economies with enhanced healthcare infrastructure is projected to stimulate the procedure rate at hospitals. As a result, accessibility to an effective treatment coupled with the rising admissions with chronic soft tissue injuries will boost patient visits to hospitals.
 

High product acceptance in the North America region owing to growing healthcare sector is set to boost regional industry statistics

U.S. dominated the North America market with a significant market share in 2021 and is anticipated to expand at a considerable pace to reach more than USD 7,242 million by 2030. The significant market share is attributable to several factors such as the presence of major business players, an increase in the demand for tissue repair products, etc. The presence of prominent players such as Zimmer Biomet, Stryker Corporation, and Arthrex among others is engaged in new product development & commercialization that facilitates the industrial expansion in the region.
 

Soft tissue repair products comprising tissue patches and xenografts play a crucial role in plastic surgeries. According to the American Society of Plastic Surgeons (ASPS) procedural statistics, in 2020, around 1.8 million surgical cosmetic procedures and 15.9 million minimally invasive cosmetic procedures were performed in the U.S. Moreover, ongoing advancements in product development, growing healthcare expenditure, and the availability of well-equipped surgical care facilities are stimulating the product demand positively.
 

Strategies adopted by major market players will surge the industry growth

Some of the major market players operating in the soft tissue repair industry are Smith & Nephew Plc., Medtronic Plc., Arthrex, Inc, Medprin Biotech, Zimmer Biomet, Stryker Corporation, and Baxter International, Inc. among others. These market players concentrate on strategic developments such as partnerships, new product launch & commercialization, vertical integration for business expansion. Furthermore, these players are heavily investing in R&D activities that enables them to innovative & capitalize on these products that further helps to garner maximum revenue in the market.
 

Recent industry developments:

• In December 2019, Medtronic received U.S. FDA approval for its Dextile Anatomical Mesh. This hernia repair mesh provides wide coverage of the myopectineal orifice to minimize the risk of recurrence and maintain shape after trocar passage. This approval supported the company to broaden its product portfolio and strengthen its market presence.
   
• In February 2019, Smith and Nephew launched the Double ENDOBUTTON Fixation Device after receiving the U.S. FDA clearance. This medical device is intended for the treatment of anterior glenoid bone loss using the Latarjet or bone block procedure (allograft or autograft). This launch helped the company in strengthening its tissue repair product portfolio.
   

Soft tissue repair market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030, for the following segments:

Click here to Buy Section of this Report

By Product

• Tissue Patch/Matrix  
  • Biological Mesh
    • Allograft
    • Xenograft
  • Synthetic Mesh
• Tissue Fixation Devices
  • Suture Anchors
  • Sutures
  • Interference Screws
  • Others

By Application

• Hernia Repair
• Orthopedic
• Skin Repair
• Dural Repair
• Others

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Clinics

The above information is provided for the following regions and countries:

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia  
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE